Breadcrumb links

Navigation

Greens can help keep breast cancer at bay

11 October 2006

Scientists have found that a molecule in vegetables such as broccoli and cabbage can inhibit the growth of breast cancer cells and could be used in conjunction with drugs to help fight the cancer. Their most recent findings were published in Carcinogenesis and are discussed today at the National Cancer Research Institute Conference.

It’s been known for some time that eating a balanced diet, including fresh fruit and vegetables, leads to a number of health benefits and can help prevent some cancers, but more precise evidence is now emerging as to the benefits of specific substances present in our food.

One research centre is looking past the essential nutrients contained in plants, to the thousands of other biologically active molecules they hold. Indole-3-carbinol (I3C) is one such molecule which is increasingly being hailed as inhibiting cancer development in both animal models and humans.

Scientists funded by the Medical Research Council at the University of Leicester decided to look at the impact of I3C on 4 different types of breast cancer cells. They found that the substance altered the receptors in three of the cell types. This change could make the cancer cells more vulnerable to anticancer drugs which also target these receptors, making the drugs more effective.

Professor Margaret Manson who led the research says:

“Although we need to carry out further studies on tumours removed from patients, the potential benefits are clear. Dietary agents are kind to normal cells at doses which can slow down or kill cancer cells. Combining them with drugs may enhance the drugs’ effectiveness and could allow reduced doses to be given to patients. Many chemotherapeutic drugs are toxic substances and the smaller the dose the better for the patient.”
“As dietary substances like I3C have a proven track record of being safe for the patient, we hope that the journey to clinical trials will be relatively straightforward,” added Professor Manson

Dr Sheila Bingham Director of the Medical Research Council Centre for Nutrition and Cancer at the University of Cambridge, who is chairing today’s session at the NCRI conference said:

“This study supports the growing evidence that food can be important in altering our susceptibility to cancer and possibly survival from it, and may help to explain why fruits and vegetables are so important”

I3C is naturally present in cruciferous vegetables, but the doses which would be required in potential breast cancer treatments would have to be formulated to ensure they were high enough, delivered in the right way and reaching the right areas. It is also thought I3C may have a similar impact on colon cancer cells.

However, the research also confirms the preventative qualities of I3C, demonstrating how it is able to protect us from carcinogens. There are thousands of other molecules present in fruit and vegetables which could have similar properties. The case gets stronger everyday to ensure sufficient levels of fruit and vegetables in our diets.

“It is notoriously hard to conduct large-scale studies looking at the cancer preventing effects of these substances in our food, but the in vitro evidence is growing that these agents would make an ideal addition to preventive and combinatorial anti-cancer strategies,” said Prof Manson

Notes to editors:

  • 1. ‘EGFR and Src are involved in indole-3-carbinol induced death and cell cycle arrest of human breast cancer cells’ was published in Carcinogenesis on September 6th 2006.
  • 2. Cruciferous vegetables include: broccoli, brussels sprouts, cabbage, cauliflower, daikon radish, kale, kohlrabi, mustard/chard greens, parsnips, rutabagas, turnips, and watercress.
  • 3. The Cancer Biomarkers and Prevention Group was formed in 2001 by researchers at the University of Leicester with a major interest in chemoprevention. The group has now expanded as part of the Department of Cancer Studies and Molecular Medicine. At present it comprises some forty research workers in three areas. The group is excellently equipped for work involving analytical chemistry, molecular epidemiology, cellular and molecular biology, drug metabolism, in vivo-models of carcinogenesis and small scale clinical trials. The budget of the combined group exceeds 1.5 million pounds per annum, with sponsorship mainly by the UK Medical Research Council, US National Cancer Institute, European Union, Cancer Research UK, Association for international Cancer Research and the pharmaceutical industry.
  • 4. The Medical Research Council (MRC) is funded by the UK tax-payer. It aims to improve human health. The research it supports and the scientists it trains meet the needs of the health services, the pharmaceutical and other health-related industries and universities. The MRC has funded work which has led to some of the most significant discoveries and achievements in medicine in the UK.
  • Phone: 020 7637 6011
    Press.office@headoffice.mrc.ac.uk

    MRC YouTube channel

                
    Contact Us
    • Comment?
    • Question?
    • Request?
    • Complaint?

    Get in touch

    This page as PDF